Product Images Dextrose

This is a description of a medicine called DEXTROSE INJECTION, which is a sterile, nonpyrogenic, single dose container comprising 70gm of Dextrose, hydrous, USP in water for injection. It is a hypertonic solution with an osmolarity of 3532 mOsmol/LITER (calc) and a pH of 43 (321065) and specific gravity of 1.23. This injection must only be administered after dilution via a central venous catheter due to its hypertonic nature. It comes in a 1000mL partial-fill container, and users should exercise caution since additives may be incompatible. The package insert provides information on dosage and administration. The solution should not be used unless the solution is clear, closure is intact, container undamaged, and minute leaks are checked by squeezing. The medicine should be kept at room temperature (25°C/77°F) and protected from excessive heat and freezing. RX ONLY.*

This is a 20% Dextrose Injection, USP with a volume of 500 mL and an NDC (National Drug Code) of 0990-7935-19. The solution is hypertonic and caution should be taken when administering. It should only be used after dilution and it is not recommended for blood transfusions due to the possible formation of rouleau. The solution comes in a single-dose container for intravenous use, and it should not be used in series connections. The solution contains DEHP, which might be incompatible with some additives. It is produced by ICU Medical, Inc. of Lake Forest, Illinois. The usual dosage is not provided and the text comes with a reference to an insert.*

This appears to be a packaging label for a medical product. It contains instructions to tear at a notch to open the packaging. The packaging is a moisture and oxygen barrier, which must not be removed until ready for use. Before opening, check for damage, and discard if the packaging is damaged. The unit should be stored at room temperature and protected from freezing. After opening, check for leaks by squeezing the container. If leaks are found, discard the solution as sterility may be affected. The label also indicates that the product is for medical use only and is manufactured by ICU Medical, Inc., located in Illinois, USA.*

This text describes a medication called Dextrose Injection, USP. It is a hypertonic solution, meaning it has a higher concentration of solutes compared to normal body fluids. It should only be administered after dilution and via a central venous catheter due to its high concentration. The dosage and administration instructions are included in the package insert. The medication should not be used if the solution is not clear, if the closure is not intact, or if there is any damage to the container. It should not be used in series connections. Additives may be incompatible, and it is recommended to consult with a pharmacist before introducing any additives. The medication should be stored at room temperature, protected from excessive heat and freezing. The container contains DEHP.*

This is a set of instructions for opening and handling a medical unit. The overwrap should not be removed until ready to use, and any tears or holes in the overwrap mean the unit should be discarded. The unit should be stored at a specific temperature range and protected from freezing. After opening the overwrap, the container should be checked for leaks. The manufacturer is ICU Medical, based in Illinois, USA.*

This is a description of a 40% Dextrose Injection, USP in a 500mL partial-fill container with NDC number 0990-7937-19. Each 100mL of the solution contains 40g of Dextrose in water for injection. The solution is hypertonic and can only be administered after dilution via a central venous catheter. Additives may be incompatible and should only be added using aseptic technique. This is a single-dose container for intravenous use and should not be used in series connections. It is important to consult a pharmacist regarding compatibility and use. The container should be clear and undamaged before use. Contains DEHP. Manufacturer is ICU Medical, Inc. pH is 4.3. Not for use in blood transfusions due to possible rouleau formation.*

This text provides instructions for opening and handling a medical unit, which is contained within a moisture and oxygen barrier overwrap. The unit should not be removed until ready for use and should be visually inspected for any damage to the overwrap. The unit should be promptly used once opened and stored at a controlled room temperature. If any leaks are found, the solution should be discarded as sterility may be compromised. The text also includes the manufacturer's name and location.*

This is a 30% dextrose injection in a 500 mL partial-fill container. It contains dextrose, hydrous, 30g in water for injection, and has a pH of 4.3. It is hypertonic and should be administered only after dilution via central venous catheter. Additives may be incompatible, and if introduced, use aseptic technique, mix thoroughly, and do not store. It is for intravenous use only and must not be used in series connections. It is a single-dose container and sterilized, nonpyrogenic. If the solution is clear and the container is undamaged, it may be used. Contains DEHP.*

The given text is an instruction set for a medical product that comes with an overwrap. It instructs the user to tear open the product using the notch and instructs the user not to remove the product until it is ready for use to maintain its oxygen barrier. It also advises checking the overwrap for tears or holes and discarding if damaged. The unit should be used promptly after opening the pouch, and it should be stored at a temperature range of 20 to 25°C. If the product is exposed to freezing, it should be protected, and any leaks found after removing the overwrap should be considered a risk of impaired sterility. The given text belongs to ICU Medical, Inc. from Lale Forest, Illinois, USA.*